| Andrea Cortes Dobson, PA | |
|
318 2nd St S, Nampa, ID 83651-3765 | |
| (208) 467-3006 | |
| (208) 467-1155 |
| Full Name | Andrea Cortes Dobson |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 7 Years |
| Location | 318 2nd St S, Nampa, Idaho |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366952285 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | PA-1654 (Idaho) | Secondary |
| 363A00000X | Physician Assistant | PA-1654 (Idaho) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dermatology Center Of Canyon County | 3072589209 | 5 |
News Archive
Alkermes, Inc. today announced that results from the phase 3 clinical study of VIVITROL® (naltrexone for extended-release injectable suspension) in opioid dependence have been published by The Lancet. The six-month, phase 3 trial met its primary endpoint and showed significantly greater opioid-free weeks among patients treated with VIVITROL, compared to placebo.
A new study of sleepwalkers found an intriguing paradox: Although sleepwalkers have an increased risk for headaches and migraines while awake, during sleepwalking episodes they are unlikely to feel pain even while suffering an injury.
University of Iowa researchers have identified a molecular pathway in blood vessels that controls blood pressure and vascular function and may help explain why certain drugs for type II diabetes also appear to lower patients' blood pressure.
Children born through medically assisted reproduction, such as IVF, are at higher risk of being premature and to be born low birth weight, but it's unlikely to be due to the procedures used, according to a new study published in The Lancet from the London School of Economics and Political Science.
Today DePuy Synthes Spine, Part of the Johnson & Johnson Family of Companies, launched the SYNFIX Evolution System, a new implant for stand-alone Anterior Lumbar Interbody Fusion (ALIF).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Cortes Dobson, PA 318 2nd St S, Nampa, ID 83651-3765 Ph: (208) 467-3006 | Andrea Cortes Dobson, PA 318 2nd St S, Nampa, ID 83651-3765 Ph: (208) 467-3006 |
News Archive
Alkermes, Inc. today announced that results from the phase 3 clinical study of VIVITROL® (naltrexone for extended-release injectable suspension) in opioid dependence have been published by The Lancet. The six-month, phase 3 trial met its primary endpoint and showed significantly greater opioid-free weeks among patients treated with VIVITROL, compared to placebo.
A new study of sleepwalkers found an intriguing paradox: Although sleepwalkers have an increased risk for headaches and migraines while awake, during sleepwalking episodes they are unlikely to feel pain even while suffering an injury.
University of Iowa researchers have identified a molecular pathway in blood vessels that controls blood pressure and vascular function and may help explain why certain drugs for type II diabetes also appear to lower patients' blood pressure.
Children born through medically assisted reproduction, such as IVF, are at higher risk of being premature and to be born low birth weight, but it's unlikely to be due to the procedures used, according to a new study published in The Lancet from the London School of Economics and Political Science.
Today DePuy Synthes Spine, Part of the Johnson & Johnson Family of Companies, launched the SYNFIX Evolution System, a new implant for stand-alone Anterior Lumbar Interbody Fusion (ALIF).
› Verified 6 days ago